Abstract
Introduction

Protein C is a vitamin K-dependent zymogen of serine protease that inhibits blood coagulation by the proteolytic inactivation of factors Va and VIIIa (1). Individuals affected with protein C deficiency are at risk for arterial or venous thrombosis (2). The diagnosis of protein C deficiency has been based on the laboratory assay of plasma protein C antigen and activity levels (3). Protein C deficiency has phenotypically been classified into two types. Type I deficiency, the most common, is characterized by the parallel reduction of protein C activity and antigen levels due to the reduced synthesis or stability of normally functioning molecules. In type II deficiency, protein C activity is reduced to a greater extent than the antigen due to the synthesis of an abnormal protein C molecule exhibiting a reduced specific activity (4). Protein C deficiencies are inherited as an autosomal dominant trait. The protein C gene resides on chromosome 2 and comprises 9 exons (5). Researchers have found over 160 different mutations of the protein C gene that lead to the absence, or a defective form, of protein C (6)
.
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). The patient's mother also had normal protein C and S antigen levels and activity (Table 3) .
Gene analysis was performed in the patient, his father, his mother and sister after written informed consent was obtained from all four subjects.
This genetic analysis was approved by our institutional ethical committee and genetic counseling was appropriately provided to the family. Isolation of genomic DNA from whole blood was followed by PCR/direct sequencing analysis of the protein C gene. DNA sequence was performed (Fig. 3) . This mutation was not found in the patient's mother or the patient's sister (Fig. 3) (15, 16) . (19) 
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In heterozygous deficiency, the levels of plasma protein C are usually between 35-65% of normal level, whereas the majority of normal individuals have levels between 70-130% (10). The protein C deficiency members with genetic mutation in this study had protein C activities between 28-43% of the normal level, suggesting that the two affected individuals are in a heterozygous state with autosomal dominant inheritance of low penetrance with regard to thrombosis (17). Both a quantitative and qualitative decrease in protein C were recognized, the former being type I deficiency and the latter, type II (18). The initial diagnosis of either form involves functional activity assay while differentiation between the two also requires an antigenic immunological assay
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antigen.
In this paper, we identified the same C to T change at nucleotide number 6,218 of the protein C gene in the patient and his father. This missense mutation caused CGG coding for arginine-169 in the heavy chain to be changed to TGG coding for tryptophan. This mutation abolishes the site of thrombin cleavage that activates protein C (20) . However, unaffected family members without protein C deficiency showed the same pattern as those of normal control subjects.
The identified missense mutation in this study was previously reported. Sakata (21) reported that all 7 Japanese families had type I deficiency. Reitsma et al (6) (25) . In the present case protein C activity seemed to recover in the patient compared to his father (Table 3) , which might also suggest a possible role of C-154T mutation. The nucleotides of the protein C gene in this are numbered according to Foster et al (26) . f e c t s o f P r o t e i n C De f i c i e n c y F o u n d i n J a p a n e s e  S u b j e c t s T a b l e 5 . Ge n e t i c De f e c t s o f P r o t e i n C De f i c i e n c y F o u n d i n S u b j e c t 
et al examined 67 Japanese families with protein C deficiency including the results of other studies in 10 families (21). They identified 39 different gene defects, including 29 missense mutations, 2 nonsense mutations, 4 deletions and 4 splice site mutations (Table 4). Of 29 missense mutations, 21 were type I deficiency and only 8 were type II deficiency. The identified missense mutation in this study (Arg169Trp) was previously reported in 7 Japanese families and in 10 families worldwide (mutation of a CG to either TG or CA) (Tables 4, 5) (6, 21). Sakata et al
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